tiprankstipranks
National Health Investors (MX:NHI)
:NHI
Mexico Market
NHI
National Health Investors
RESEARCH TOOLSreports

National Health Investors (NHI) Ratios

0 Followers

National Health Investors Ratios

MX:NHI's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, MX:NHI's free cash flow was decreased by $ and operating cash flow was $0.59. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.59 2.48 0.96 1.16 3.42
Quick Ratio
 0.59 2.48 0.96 1.16 3.42
Cash Ratio
 0.06 0.16 0.06 0.07 0.17
Solvency Ratio
 0.19 0.18 0.17 0.17 0.11
Operating Cash Flow Ratio
 0.47 1.92 0.50 0.57 1.65
Short-Term Operating Cash Flow Coverage
 0.57 1.92 0.63 0.75 4.41
Net Current Asset Value
$ -1.07B$ -946.76M$ -832.28M$ -839.24M$ -834.51M
Leverage Ratios
Debt-to-Assets Ratio
 0.43 0.42 0.44 0.46 0.46
Debt-to-Equity Ratio
 0.82 0.76 0.84 0.91 0.90
Debt-to-Capital Ratio
 0.45 0.43 0.46 0.48 0.47
Long-Term Debt-to-Capital Ratio
 0.35 0.41 0.37 0.42 0.47
Financial Leverage Ratio
 1.89 1.84 1.91 1.98 1.97
Debt Service Coverage Ratio
 0.65 1.55 0.68 0.86 2.12
Interest Coverage Ratio
 4.46 3.40 3.28 3.22 3.13
Debt to Market Cap
 0.38 0.33 0.38 0.47 0.49
Interest Debt Per Share
 27.43 26.05 27.42 27.44 26.58
Net Debt to EBITDA
 3.97 4.06 4.25 4.28 6.31
Profitability Margins
Gross Profit Margin
64.67%36.70%96.67%96.40%96.48%
EBIT Margin
51.54%52.35%57.50%59.37%38.77%
EBITDA Margin
72.88%74.50%78.81%81.25%64.25%
Operating Profit Margin
45.45%51.47%54.85%55.90%47.72%
Pretax Profit Margin
38.32%37.19%40.75%42.02%23.51%
Net Profit Margin
38.47%37.56%41.17%42.41%23.87%
Continuous Operations Profit Margin
38.15%37.19%40.77%42.02%23.55%
Net Income Per EBT
100.41%100.99%101.02%100.95%101.52%
EBT Per EBIT
84.31%72.26%74.29%75.16%49.27%
Return on Assets (ROA)
5.63%5.08%5.28%5.45%2.65%
Return on Equity (ROE)
10.96%9.34%10.10%10.82%5.23%
Return on Capital Employed (ROCE)
8.11%7.29%8.36%8.26%5.54%
Return on Invested Capital (ROIC)
6.91%6.97%7.26%7.42%5.45%
Return on Tangible Assets
5.63%5.08%5.28%5.45%2.65%
Earnings Yield
4.90%3.97%4.54%5.60%2.84%
Efficiency Ratios
Receivables Turnover
 2.07 1.30 0.90 0.93 0.87
Payables Turnover
 3.30 0.00 0.30 0.34 0.38
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.17 0.00 0.00 0.00 0.00
Asset Turnover
 0.15 0.14 0.13 0.13 0.11
Working Capital Turnover Ratio
 -3.02 4.51 20.09 1.99 0.78
Cash Conversion Cycle
 65.52 280.21 -830.97 -693.18 -548.54
Days of Sales Outstanding
 176.18 280.21 403.36 394.37 417.47
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 110.66 0.00 1.23K 1.09K 966.01
Operating Cycle
 176.18 280.21 403.36 394.37 417.47
Cash Flow Ratios
Operating Cash Flow Per Share
 5.18 5.12 4.75 4.25 4.14
Free Cash Flow Per Share
 4.87 4.70 4.39 4.16 4.04
CapEx Per Share
 0.31 0.43 0.36 0.09 0.10
Free Cash Flow to Operating Cash Flow
 0.94 0.92 0.92 0.98 0.98
Dividend Paid and CapEx Coverage Ratio
 1.32 1.27 1.21 1.15 1.11
Capital Expenditure Coverage Ratio
 16.55 12.03 13.23 49.28 40.04
Operating Cash Flow Coverage Ratio
 0.20 0.21 0.18 0.16 0.16
Operating Cash Flow to Sales Ratio
 0.58 0.63 0.62 0.58 0.67
Free Cash Flow Yield
6.92%6.15%6.33%7.46%7.73%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 20.27 25.20 22.07 17.86 35.21
Price-to-Sales (P/S) Ratio
 7.86 9.46 9.07 7.58 8.40
Price-to-Book (P/B) Ratio
 2.17 2.35 2.22 1.93 1.84
Price-to-Free Cash Flow (P/FCF) Ratio
 14.46 16.25 15.79 13.41 12.94
Price-to-Operating Cash Flow Ratio
 13.58 14.90 14.60 13.14 12.62
Price-to-Earnings Growth (PEG) Ratio
 2.07 -7.19 69.08 0.04 -0.57
Price-to-Fair Value
 2.17 2.35 2.22 1.93 1.84
Enterprise Value Multiple
 14.76 16.75 15.75 13.61 19.39
Enterprise Value
 4.66B 4.72B 4.16B 3.54B 3.47B
EV to EBITDA
 14.76 16.75 15.75 13.61 19.39
EV to Sales
 10.75 12.48 12.41 11.06 12.46
EV to Free Cash Flow
 19.78 21.45 21.62 19.57 19.18
EV to Operating Cash Flow
 18.59 19.66 19.98 19.17 18.70
Tangible Book Value Per Share
 32.68 32.85 31.59 29.36 28.81
Shareholders’ Equity Per Share
 32.44 32.46 31.17 28.90 28.37
Tax and Other Ratios
Effective Tax Rate
 <0.01 0.00 >-0.01 0.00 >-0.01
Revenue Per Share
 8.95 8.08 7.64 7.37 6.21
Net Income Per Share
 3.44 3.03 3.15 3.13 1.48
Tax Burden
 1.00 1.01 1.01 1.01 1.02
Interest Burden
 0.74 0.71 0.71 0.71 0.61
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.04 0.00 0.07 0.06 0.09
Stock-Based Compensation to Revenue
 0.01 0.00 0.00 0.01 0.03
Income Quality
 1.51 1.69 1.51 1.37 2.83
Currency in USD